Hims & Hers Health
HIMS
$12.27
Share price
-0.57%
Change (1 day)
9.65%
Change (1 year)
Operating Margin for Hims & Hers Health (HIMS)
Operating Margin as of April 2024 (TTM): -9.60%
According to Hims & Hers Health's latest financial reports and stock price the company's current Operating Margin is -9.60%. At the end of 2022 the company had an Operating Margin of -12.47%.
Operating Margin history for Hims & Hers Health from 2020 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -12.47% | -69.4% |
| 2021 | -40.75% | 237.03% |
| 2020 | -12.09% | -86.13% |
| 2019 | -87.18% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -591.52% | 6,061.67% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -129.00% | 1,243.75% | 🇬🇧 UK |
 Novavax NVAX | -149.57% | 1,458.02% | 🇺🇸 USA |
 Novocure
NVCR | -37.52% | 290.83% | Jersey |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.